Genomic data with clinical outcome data from routine practice data from Vall d’ Hebron Institute of Oncology, Barcelona, Spain
Main goals: *To develop and implement improved strategies for routine patient prescreening in a setting of excellence (ISO 15189 flexible accreditation). * To provide cutting-edge applications in cancer genomics through the use of novel technologies and protocol development. * To prioritize translational projects and partnerships that reinforce VHIO’s renowned excellence in oncology, such as those we are currently pursuing with our Thoracic Tumors Group, led by Enriqueta Felip, and Gastrointestinal & Endocrine Tumors Group, directed by Josep Tabernero.
- Study design
- Patients' cohort
- Sources of Recruitment
Number of participants
- Number of participants
- Number of participants with biosamples
Availability of data and biosamples
No coverage data about the variables classifications are available.